Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-DEF
NCT02175225Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2014
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of deferoxamine in intracerebral hemorrhage (ICH), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2014; status: completed.
02
Drugs
deferoxamine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02175225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175225.